SCHEMBL3785555

SCHEMBL3785555

Cc1c(N)cccc1-c1cccc(N)c1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 5/20 0.50
CYP3A4 P08684 2/20 0.50
TSHR P16473 2/20 0.50
PIK3CA P42336 1/20 0.50
MAOA P21397 1/20 0.48
BRD4 O60885 1/20 0.42
RECQL P46063 2/20 0.42
CASP1 P29466 1/20 0.42
ALDH1A1 P00352 2/20 0.42
MAOB P27338 1/20 0.42
METAP2 P50579 1/20 0.41
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 1/20 0.40
PSIP1 O75475 1/20 0.40
AXL P30530 1/20 0.40
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
KIT P10721 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3789628 0.86 MAOA (0.47) MAP4K4CYP3A4TSHRPIK3CAMAOA
SCHEMBL31607625 0.86 MAOA (0.47) MAP4K4CYP3A4TSHRPIK3CAMAOA
SCHEMBL29636990 0.81 ALDH1A1 (0.62) MAP4K4CYP3A4MAOABRD4RECQL
SCHEMBL29788122 0.81 ALDH1A1 (0.62) MAP4K4CYP3A4TSHRPIK3CAMAOA
SCHEMBL30839741 0.81 ALDH1A1 (0.62) MAP4K4CYP3A4MAOABRD4RECQL
SCHEMBL365320 0.81 ALDH1A1 (0.62) MAP4K4CYP3A4TSHRPIK3CAMAOA
SCHEMBL2442638 0.81 ALDH1A1 (0.62) MAP4K4CYP3A4MAOABRD4RECQL
SCHEMBL31607638 0.81 ALDH1A1 (0.62) MAP4K4CYP3A4MAOABRD4RECQL
SCHEMBL3785934 0.81 TSHR (0.46) MAP4K4CYP3A4TSHRPIK3CABRD4
SCHEMBL3785931 0.81 MAOA (0.45) MAP4K4CYP3A4TSHRMAOABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115466251-A Fused heterocyclic compound, preparation method thereof, pharmaceutical composition and application 中国医学科学院药物研究所 2022-12-13 CN disclosed
CN-113603663-A Method for preparing biphenyl dianhydride isomer through ultrasonic-assisted catalytic coupling 哈尔滨工业大学(威海) 2021-11-05 CN disclosed
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 MAP4K4 3704/4885CYP3A4 177/4885TSHR 1688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.